2016 to 2021 Saw Drop in Cervical Cancer Mortality for Women Younger Than 25
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 3, 2024 -- From 2016 to 2021, there was a decrease in cervical cancer deaths among U.S. women aged younger than 25 years, according to a research letter published online Nov. 27 in the Journal of the American Medical Association.
Noting that the incidence of cervical cancer decreased during 2012 to 2019 among U.S. women aged younger than 25 years, Poria Dorali, Ph.D., from the Medical University of South Carolina in Charleston, and colleagues analyzed cervical cancer mortality data for women aged younger than 25 years from 1992 to 2021 from the National Center for Health Statistics.
The researchers found that 398 cervical cancer deaths were reported between 1992 and 2021 among women younger than 25 years. There was an initial gradual decline of 3.7 percent per year in cervical cancer mortality from 1992-1994 to 2013-2015; from 2013-2015 to 2019-2021, there was a decline of 15.2 percent per year. During the same time period, the number of cervical cancer deaths decreased from 55 to 35 to 13 in 1992-1994, 2013-2015, and 2019-2021, respectively. Based on projected mortality rates, an estimated 26 additional cervical cancer deaths would have been expected to occur between 2016 and 2021, assuming that the trend from 1992-1994 to 2013-2015 continued.
"Since the beginning of the COVID-19 pandemic, HPV vaccination coverage has not improved and a troubling decline occurred (from 79.3 percent in 2022 to 75.9 percent in 2023) among the most recent generation of U.S. adolescents," the authors write. "The findings from this study highlight the urgency to improve HPV vaccination coverage."
Two authors disclosed ties to Value Analytics Labs; one also disclosed ties to Merck.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-05 00:00
Read more

- Therapeutic Vaccine May Fight Advanced Kidney Cancer
- Benefits of Pediatric Obesity Treatment Endure Into Young Adulthood
- Smog During Pregnancy Threatens Newborn Health
- COVID-19 Linked to Chronic Fatigue Syndrome
- Ethnoracial Disparities Seen in Access to Genetic Testing in Pediatric Neurology
- Arbor Biotechnologies Announces FDA Orphan Drug and Rare Pediatric Disease Designations Granted to ABO-101 for the Treatment of Primary Hyperoxaluria Type 1 (PH1)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions